Investigation of the Antifibrotic Effect of IFN-γ on Fibroblasts in a Cell Culture Model of Peyronie's Disease

European Urology

Volumn 53, Issue 2, 2008, Pages 425-431

  Haag, Simone M ^a   Hauck, Ekkehard W ^a   Eickelberg, Oliver ^b   Szardening Kirchner, Carolin ^a   Diemer, Thorsten ^a   Weidner, Wolfgang ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

Author keywords

Cell culture; Interferon gamma; Peyronie's disease; Smad; Transforming growth factor

Indexed keywords

ANTIFIBROTIC AGENT; BONE MORPHOGENETIC PROTEIN 2; GAMMA INTERFERON; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FIBROBLAST; FIBROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; MALE; MOLECULAR PROBE; PATHOGENESIS; PEYRONIE DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

BIOPSY; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; FIBROBLASTS; HUMANS; IMMUNOENZYME TECHNIQUES; INTERFERON TYPE II; MALE; PENILE INDURATION; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 37349007413     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.06.036     Document Type: Article

References (19)

1. Hauck E.W., Diemer T., Schmelz H.U., and Weidner W. A critical analysis of nonsurgical treatment of Peyronie's disease. Eur Urol 49 (2006) 987-997
2. El-Sakka A.I., Hassoba H.M., Chui R.M., Bhatnagar R.S., Dahiya R., and Lue T.F. An animal model of Peyronie's like condition associated with an increase of transforming growth factor beta mRNA and protein expression. J Urol 158 (1997) 2284-2290
3. Massagué J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol 1 (2000) 169-178
4. Eickelberg O., Pansky A., Koehler E., et al. Molecular mechanisms of TGF-beta antagonism by interferon-gamma and cyclosporine A in lung fibroblasts. FASEB J 15 (2001) 797-806
5. Kardioglu A., Akman T., Sanli O., Gurkan L., Cakan M., and Celtik M. Surgical treatment of Peyronie's disease: a critical analysis. Eur Urol 50 (2006) 235-248
6. Ralph D.J. The surgical treatment of Peyronie's disease. Eur Urol 50 (2006) 196-198
7. Eickelberg O., Pansky A., and Mussmann R. Transforming growth-factor-beta1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts. J Biol Chem 274 (1999) 12933
8. Gholami S.S., Gonzalez-Cadavid N.F., Lin C.S., Rajfer J., and Lue T.F. Peyronie's disease: a review. J Urol 169 (2003) 1234-1241
9. Haag S.M., Hauck E.W., Szardening-Kirchner C., et al. Alterations in the transforming growth factor (TGF)-β pathway as a potential factor in the pathogenesis of Peyronie's disease. Eur Urol 51 (2007) 255-261
10. Lutz M., and Knaus P. Integration of the TGF-beta pathway into the cellular signaling network. Cell Signal 14 (2002) 977-988
11. Hellstrom W.J.G., and Bivalacqua T.J. Peyronie's disease: etiology, medical, and surgical therapy. J Androl 21 (2000) 347-354
12. Hellstrom W.J.G., Kendirci M., Matern R., et al. Single-blind, multi-center, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon α-2b for minimally invasive treatment for Peyronie's disease. J Urol 176 (2006) 394-398
13. Kendirci M., Usta M.F., Matern R.V., Nowfar S., Sikka S.C., and Hellstrom W.J. The impact of intralesional interferon alpha-2b injection thrapy on penile hemodynamics in men with Peyronie's disease. J Sex Med 2 (2005) 709-715
14. Brake M., Loertzer H., Horsch R., and Keller H. Treatment of Peyronie's disease with local interferon-α 2b. BJU Int 87 (2001) 654-657
15. Wegner H.E., Andresen R., Knispel H.H., and Miller K. Local interferon-alpha 2b is not an effective treatment in early-stage Peyronie's disease. Eur Urol 32 (1997) 190-193
16. Duncan M.R., Berman B., and Nseyo U.O. Regulation of the proliferation and biosynthetic activities of cultured human Peyronie's disease fibroblasts by interferons-alpha, -beta and -gamma. Scand J Urol Nephrol 141 (1991) 89-94
17. Blobe G.C., Schiemann W.P., and Lodish H.F. Role of transforming growth factor β in human disease. N Engl J Med 342 (2000) 1350-1358
18. Ulloa L., Doody J., and Massagué J. Inhibition of transforming growth-factor-beta/ SMAD signaling by the Interferon-gamma/STAT pathway. Nature 397 (1999) 710-713
19. Kuga H., Morisaki T., Nakamura K., et al. Interferon-gamma suppresses transforming growth factor-beta-induced invasion of gastric carcinoma cells through cross-talk of Smad pathway in a three-dimensional culture model. Oncogene 22 (2003) 7838-7847